Interactions of nanomaterials with the immune system.

Evaluation of the immunomodulatory potentials of nanomaterials is essential for developing safe and consumer-friendly nanotechnology. Various nanomaterials interact with the immune system, in a beneficial or deleterious way, but mechanistic details about such interactions are scarce. A lack of agreed-upon guidelines for evaluating the immunotoxicity of nanoparticles (NPs) adds to the complexity of the issue. Various review articles have summarized the immune system interactions of biodegradable NPs (with pharmaceutical uses), but such information is largely lacking for nonbiodegradable NPs. Here we give an overview of interactions of nonbiodegradable, persistent NPs with the immune system. Particular emphases include key factors that shape such interactions, cell-specific responses, allergy and immune-sensitive respiratory disorders.

[1]  M F Hoylaerts,et al.  Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. , 2001, American journal of respiratory and critical care medicine.

[2]  T. Yoshikawa,et al.  Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. , 1997, American journal of respiratory and critical care medicine.

[3]  V. Hox,et al.  Mechanisms of occupational asthma caused by low-molecular-weight chemicals , 2010 .

[4]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[5]  D. Tollerud,et al.  Matrix metalloproteinase-2 and -9 are induced differently by metal nanoparticles in human monocytes: The role of oxidative stress and protein tyrosine kinase activation. , 2008, Toxicology and applied pharmacology.

[6]  T. Yoshikawa,et al.  Size Effects of Nanomaterials on Lung Inflammation and Coagulatory Disturbance , 2008, International journal of immunopathology and pharmacology.

[7]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[8]  S. Krämer,et al.  Particle size and activation threshold: a new dimension of danger signaling. , 2010, Blood.

[9]  Seung-Heon Shin,et al.  The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. , 2007, International immunopharmacology.

[10]  Katrin Schwarz,et al.  Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.

[11]  B. Granum,et al.  Adjuvant activity of particulate pollutants in different mouse models. , 2000, Toxicology.

[12]  Jenny R. Roberts,et al.  Skin as a route of exposure and sensitization in chronic beryllium disease. , 2003, Environmental health perspectives.

[13]  Alison Elder,et al.  Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[14]  V. Hornung,et al.  Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells , 2011, Nanotoxicology.

[15]  Bengt Fadeel,et al.  Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. , 2011, Toxicology and applied pharmacology.

[16]  K. Jensen,et al.  Nano Titanium Dioxide Particles Promote Allergic Sensitization and Lung Inflammation in Mice , 2010, Basic & clinical pharmacology & toxicology.

[17]  A. Tres,et al.  Dendritic cell uptake of iron‐based magnetic nanoparticles , 2008, Cell biology international.

[18]  Jürgen Groll,et al.  Phagocytosis independent extracellular nanoparticle clearance by human immune cells. , 2010, Nano letters.

[19]  Kwangsik Park,et al.  Induction of pro-inflammatory signals by 1-nitropyrene in cultured BEAS-2B cells. , 2009, Toxicology letters.

[20]  Malcolm L. H. Green,et al.  Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.

[21]  H. Takano,et al.  Carbon black nanoparticles promote the maturation and function of mouse bone marrow-derived dendritic cells. , 2008, Chemosphere.

[22]  D. Girard,et al.  Activation of human neutrophils by titanium dioxide (TiO2) nanoparticles. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[23]  Z. Marković,et al.  Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60). , 2009, Biomaterials.

[24]  A. Tres,et al.  Cell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cells , 2010, Nanotechnology.

[25]  S. Keshavjee,et al.  MMP9 modulates tight junction integrity and cell viability in human airway epithelia. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[26]  Diana Boraschi,et al.  Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. , 2004, European cytokine network.

[27]  G. Liss,et al.  Diisocyanate-induced asthma: diagnosis, prognosis, and effects of medical surveillance measures. , 2002, Applied occupational and environmental hygiene.

[28]  N. Monteiro-Riviere,et al.  Penetration of intact skin by quantum dots with diverse physicochemical properties. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  J. Gimzewski,et al.  Nanodiamond and nanoplatinum liquid, DPV576, activates human monocyte-derived dendritic cells in vitro. , 2010, Anticancer research.

[30]  Jim E Riviere,et al.  Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents. , 2010, Toxicology and applied pharmacology.

[31]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[32]  Sudipta Seal,et al.  Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. , 2009, ACS nano.

[33]  Li-jun Zhu,et al.  Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. , 2010, Current drug metabolism.

[34]  Martinus Løvik,et al.  Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  D. Dinsdale,et al.  Lung exposure to nanoparticles modulates an asthmatic response in a mouse model , 2010, European Respiratory Journal.

[36]  E. Antignac,et al.  Safety assessment of personal care products/cosmetics and their ingredients. , 2010, Toxicology and applied pharmacology.

[37]  S W Burchiel,et al.  Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. , 2009, Nature nanotechnology.

[38]  Roberto Cingolani,et al.  Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.

[39]  J. Barrett,et al.  Dendritic cell internalization of foam-structured fluorescent mesoporous silica nanoparticles. , 2011, Journal of colloid and interface science.

[40]  Bengt Fadeel,et al.  Single-walled carbon nanotubes impair human macrophage engulfment of apoptotic cell corpses , 2009, Inhalation toxicology.

[41]  M. Roberts,et al.  Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety , 2007, Critical reviews in toxicology.

[42]  B. Nemery,et al.  Ammonium persulfate can initiate an asthmatic response in mice , 2010, Thorax.

[43]  B. Nemery,et al.  Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. , 2006, The Journal of allergy and clinical immunology.

[44]  J. Ponti,et al.  Cobalt nano-particles modulate cytokine in vitro release by human mononuclear cells mimicking autoimmune disease. , 2006, International journal of immunopathology and pharmacology.

[45]  David Leong,et al.  Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. , 2007, Molecular pharmaceutics.

[46]  Sara Linse,et al.  The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. , 2007, Advances in colloid and interface science.

[47]  R. Müller,et al.  Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[48]  Benoit Nemery,et al.  Health impact of nanomaterials? , 2004, Nature Biotechnology.

[49]  R. Hamel,et al.  Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: Need for multiparametric evaluation due to adsorption artifacts , 2009, Inhalation toxicology.

[50]  Kwangsik Park,et al.  Intratracheal instillation of platinum nanoparticles may induce inflammatory responses in mice , 2010, Archives of pharmacal research.

[51]  A E Nel,et al.  Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. , 1998, The Journal of allergy and clinical immunology.

[52]  Darren J. Martin,et al.  Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.

[53]  Toshikazu Yoshikawa,et al.  Effects of Airway Exposure to Nanoparticles on Lung Inflammation Induced by Bacterial Endotoxin in Mice , 2006, Environmental health perspectives.

[54]  K. Dawson,et al.  Detecting Cryptic Epitopes Created by Nanoparticles , 2006, Science's STKE.

[55]  S M Moghimi,et al.  Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers. , 2002, Biochimica et biophysica acta.

[56]  Marina A Dobrovolskaia,et al.  Nanoparticles and the immune system. , 2010, Endocrinology.

[57]  Christian Mühlfeld,et al.  Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. , 2008, Swiss medical weekly.

[58]  G. Choquet-Kastylevsky,et al.  Responses of the Immune System to Injury , 2000, Toxicologic pathology.

[59]  Jie Li,et al.  Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1 , 2004, The Journal of Immunology.

[60]  T. Yoshikawa,et al.  Effects of nano particles on cytokine expression in murine lung in the absence or presence of allergen , 2006, Archives of Toxicology.

[61]  Pei-Shan Liu,et al.  Toluene diisocyanate (TDI) induces calcium elevation and interleukine-4 (IL-4) release - early responses upon TDI stimulation. , 2010, The Journal of toxicological sciences.

[62]  A. Bucht,et al.  Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the Dark Agouti rat , 2011, Journal of immunotoxicology.

[63]  J. Ceuppens,et al.  Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[64]  Diem-Kieu H. Ngo.  FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) , 2008 .

[65]  Wolfgang Kreyling,et al.  Ultrafine Particles Cross Cellular Membranes by Nonphagocytic Mechanisms in Lungs and in Cultured Cells , 2005, Environmental health perspectives.

[66]  Ran Liu,et al.  Small-sized titanium dioxide nanoparticles mediate immune toxicity in rat pulmonary alveolar macrophages in vivo. , 2010, Journal of nanoscience and nanotechnology.

[67]  Y. Fujitani,et al.  Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice. , 2007, Toxicology.

[68]  A. Rao,et al.  Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation , 2011, Nanotoxicology.

[69]  Virander S. Chauhan,et al.  Induction of humoral immune response against PfMSP-1(19) and PvMSP-1(19) using gold nanoparticles along with alum. , 2011, Vaccine.

[70]  V. Castranova,et al.  Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats , 2011, Nanotoxicology.

[71]  H. Takano,et al.  Effects of Pulmonary Exposure to Carbon Nanotubes on Lung and Systemic Inflammation with Coagulatory Disturbance Induced by Lipopolysaccharide in Mice , 2008, Experimental biology and medicine.

[72]  T. Yoshikawa,et al.  Effects of nano particles on antigen-related airway inflammation in mice , 2005, Respiratory research.

[73]  C. Lemière,et al.  Persistence of airway responsiveness to occupational agents: what does it matter? , 2002, Current opinion in allergy and clinical immunology.

[74]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[75]  Saber M Hussain,et al.  Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[76]  G. Lorenzo,et al.  Hormone refractory prostate cancer (HRPC): present and future approaches of therapy. , 2006 .

[77]  Scott W Burchiel,et al.  Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[78]  V. Apostolopoulos,et al.  Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy. , 2007, Vaccine.

[79]  R. Pieters,et al.  Activation of Pulmonary Dendritic Cells and Th2-Type Inflammatory Responses on Instillation of Engineered, Environmental Diesel Emission Source or Ambient Air Pollutant Particles in vivo , 2010, Journal of Innate Immunity.

[80]  Wei Zhao,et al.  Fullerene Nanomaterials Inhibit the Allergic Response1 , 2007, The Journal of Immunology.

[81]  T. Ishida,et al.  Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[82]  Sudipta Seal,et al.  Anti-inflammatory properties of cerium oxide nanoparticles. , 2009, Small.

[83]  G. Oberdörster,et al.  Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology , 2010, Journal of internal medicine.

[84]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[85]  H. Takano,et al.  Pulmonary Exposure to Carbon Black Nanoparticles Increases the Number of Antigen-Presenting Cells in Murine Lung , 2008, International journal of immunopathology and pharmacology.

[86]  J. Ceuppens,et al.  Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[87]  Anna A Shvedova,et al.  Sequential Exposure to Carbon Nanotubes and Bacteria Enhances Pulmonary Inflammation and Infectivity. Materials and Methods , 2022 .

[88]  T. Ishida,et al.  Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.

[89]  T S Nawrot,et al.  Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10 , 2008, European Respiratory Journal.

[90]  Wiyong Kangwansupamonkon,et al.  Determination of silver nanoparticle release from antibacterial fabrics into artificial sweat , 2010, Particle and Fibre Toxicology.

[91]  Fernando Rodrigues-Lima,et al.  Nanoparticles: molecular targets and cell signalling , 2011, Archives of Toxicology.

[92]  T. Nawrot,et al.  How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice? , 2008, The Journal of allergy and clinical immunology.

[93]  D E Banks,et al.  Assessment of the relationship between isocyanate exposure levels and occupational asthma. , 1997, American journal of industrial medicine.

[94]  Parag Aggarwal,et al.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.

[95]  Alison Elder,et al.  Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. , 2010, ACS nano.

[96]  Robert H Schiestl,et al.  Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. , 2009, Cancer research.

[97]  J. Martens,et al.  Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. , 2009, Toxicology.

[98]  B. Nemery,et al.  In vitro translocation of quantum dots and influence of oxidative stress. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[99]  G. Oberdörster,et al.  Translocation and effects of ultrafine particles outside of the lung. , 2006, Clinics in occupational and environmental medicine.

[100]  R. Pieters,et al.  Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity. , 2000, Toxicology and applied pharmacology.

[101]  C. Lemière.  Persistence of bronchial reactivity to occupational agents after removal from exposure and identification of associated factors. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[102]  Y. Yoshioka,et al.  Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. , 2010, Die Pharmazie.

[103]  M. Roberts,et al.  Nanotechnology, Cosmetics and the Skin: Is There a Health Risk? , 2008, Skin Pharmacology and Physiology.

[104]  A. Schmidt-ott,et al.  Investigating the Immunologic Effects of CoCr Nanoparticles , 2009, Clinical orthopaedics and related research.

[105]  A. Nials,et al.  Mouse models of allergic asthma: acute and chronic allergen challenge , 2008, Disease Models & Mechanisms.

[106]  Ulrike Blume-Peytavi,et al.  40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. , 2006, The Journal of investigative dermatology.

[107]  B. Jonsson,et al.  Induction of structure and function in a designed peptide upon adsorption on a silica nanoparticle. , 2006, Angewandte Chemie.

[108]  Q. Liu,et al.  Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI–albumin conjugates , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.